Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan.

Saved in:
Bibliographic Details
Title: Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan.
Authors: Morita Y; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, 589-8511, Osaka, Japan. moriyasu@med.kindai.ac.jp., Tsuji Y; Pharmacovigilance Department, Kyowa Kirin Co., Ltd., Tokyo, Japan., Yasukawa T; Pharmacovigilance Department, Kyowa Kirin Co., Ltd., Tokyo, Japan., Mitani K; Department of Medicine, Dokkyo Medical University, Tochigi, Japan.
Source: International journal of hematology [Int J Hematol] 2026 Oct; Vol. 124 (4), pp. 502-520. Date of Electronic Publication: 2026 May 18.
Publication Type: Journal Article
Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1865-3774
DOI:10.1007/s12185-026-04227-w